1 |
Kuhnert F, Kirshner JR, Thurston G (2011). Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc Cell, 3, 20.
DOI
|
2 |
Kurrey NK, Jalgaonkar SP, Joglekar AV, et al (2009). Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells, 27, 2059-68.
DOI
ScienceOn
|
3 |
Kvols LK (2005). Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med, 46, S187-90.
|
4 |
Lagadec C, Vlashi E, Della DL, Dekmezian C, Pajonk F (2012). Radiation-induced reprogramming of breast cancer cells. Stem Cells, 30, 833-44.
DOI
ScienceOn
|
5 |
Lai EC (2004). Notch signaling: control of cell communication and cell fate. Development, 131, 965-73.
DOI
|
6 |
Lee SF, Srinivasan B, Sephton CF, et al (2011). Gammasecretase-regulated proteolysis of the Notch receptor by mitochondrial intermediate peptidase. J Biol Chem, 286, 27447-53.
DOI
|
7 |
Li C, Zhang Y, Lu Y, et al (2011). Evidence of the cross talk between Wnt and Notch signaling pathways in non-smallcell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines. J Cancer Res Clin Oncol, 137, 771-8.
DOI
|
8 |
Lin H, Xiong W, Zhang X, et al (2011). Notch-1 activationdependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep, 26, 925-30.
|
9 |
Lin J, Zhang XM, Yang JC, Ye YB, Luo SQ (2010). Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Arch Med Res, 41, 519-29.
DOI
|
10 |
Lin JT, Chen MK, Yeh KT, et al (2010). Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol, 17, 2976-83.
DOI
|
11 |
Lin L, Fuchs J, Li C, et al (2011). STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH/CD133 stem cell-like human colon cancer cells. Biochem Biophys Res Commun, 416, 246-51.
DOI
ScienceOn
|
12 |
Lino MM, Merlo A, Boulay JL (2010). Notch signaling in glioblastoma: a developmental drug target. BMC Med, 8, 72.
DOI
|
13 |
Liu SK, Bham SA, Fokas E, et al (2011). Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst, 103, 1778-98.
DOI
|
14 |
Maliekal TT, Bajaj J, Giri V, Subramanyam D, Krishna S (2008). The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene, 27, 5110-14.
DOI
|
15 |
McAllister SS, Weinberg RA (2010). Tumor-host interactions: a far-reaching relationship. J Clin Oncol, 28, 4022-8.
DOI
|
16 |
Mihatsch J, Toulany M, Bareiss PM, et al (2011). Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro. Radiother Oncol, 99, 300-6.
DOI
|
17 |
Mori M, Miyamoto T, Yakushiji H, et al (2012). Effects of N-[N-(3, 5-difluorophenacetyl-L: -alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells. Hum Cell, 25, 9-15.
DOI
|
18 |
Morrison R, Schleicher SM, Sun Y, et al (2011). Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol, 2011, 941876.
|
19 |
Nickoloff BJ, Osborne BA, Miele L (2003). Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene, 22, 6598-608.
DOI
ScienceOn
|
20 |
Nam Y, Aster JC, Blacklow SC (2002). Notch signaling as a therapeutic target. Curr Opin Chem Biol, 6, 501-9.
DOI
ScienceOn
|
21 |
Noguera-Troise I, Daly C, Papadopoulos NJ, et al (2006). Blockade of Dll4 inhibits tumour growth by promoting nonproductive angiogenesis. Nature, 444, 1032-7.
DOI
|
22 |
Nygren P, Glimelius B (2001). The Swedish Council on Technology Assessment in Health Care (SBU) report on Cancer Chemotherapy--Project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation. Acta Oncol, 40, 155-65.
DOI
|
23 |
Ordentlich P, Lin A, Shen CP, et al (1998). Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol, 18, 2230-39.
DOI
|
24 |
Phillips TM, McBride WH, Pajonk F (2006). The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst, 98, 1777-85.
DOI
ScienceOn
|
25 |
Piao LS, Hur W, Kim TK, et al (2012). CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett, 315, 129-37.
DOI
ScienceOn
|
26 |
Purow B (2009). Notch inhibitors as a new tool in the war on cancer: a pathway to watch, Curr Pharm Biotechnol. Curr Pharm Biotechnol, 10, 154-60.
DOI
|
27 |
Purow B (2012). Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol, 727, 305-19.
DOI
|
28 |
Ramakrishnan V, Ansell S, Haug J, et al (2012). MRK003, a gamma-secretase inhibitor exhibits promising in vitro preclinical activity in multiple myeloma and non-Hodgkin's lymphoma. Leukemia, 26, 340-8.
DOI
|
29 |
Pyo H, Choy H, Amorino GP, et al (2001). A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res, 7, 2998-3005.
|
30 |
Qi R, An H, Yu Y, et al (2003). Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res, 63, 8323-9.
|
31 |
Rasul S, Balasubramanian R, Filipovic A, et al (2009). Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer, 100, 1879-88.
DOI
|
32 |
Reichert S, Rodel C, Mirsch J, et al (2011). Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma. Radiother Oncol, 101, 51-8.
DOI
|
33 |
Searfoss GH, Jordan WH, Calligaro DO, et al (2003). Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J Biol Chem, 278, 46107-16.
DOI
|
34 |
Sethi N, Dai X, Winter CG, Kang Y (2011). Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell, 19, 192-205.
DOI
|
35 |
Sikandar SS, Pate KT, Anderson S, et al (2010). NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res, 70, 1469-78.
DOI
ScienceOn
|
36 |
Strosberg JR, Yeatman T, Weber J, et al (2012). A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer, 48, 997-1003.
DOI
|
37 |
Spalding AC, Lawrence TS (2006). New and emerging radiosensitizers and radioprotectors. Cancer Invest, 24, 444-56.
DOI
|
38 |
Squatrito M, Brennan CW, Helmy K, et al (2010). Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell, 18, 619-29.
DOI
|
39 |
Sriuranpong V, Borges MW, Ravi RK, et al (2001). Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res, 61, 3200-5.
|
40 |
Suwanjunee S, Wongchana W, Palaga T (2008). Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling. Anticancer Drugs, 19, 477-86.
DOI
|
41 |
Szumiel I (2008). Intrinsic radiation sensitivity: cellular signaling is the key. Radiat Res, 169, 249-58.
DOI
|
42 |
Teimourian S, Jalal R, Sohrabpour M, Goliaei B (2006). Downregulation of Hsp27 radiosensitizes human prostate cancer cells. Int J Urol, 13, 1221-5.
DOI
ScienceOn
|
43 |
Tien AC, Rajan A, Bellen HJ (2009). A Notch updated. J Cell Biol, 184, 621-9.
DOI
|
44 |
Tsuyada A, Chow A, Wu J, et al (2012). CCL2 mediates crosstalk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res, 72, 2768-79 .
DOI
|
45 |
Wang J, Wakeman TP, Lathia JD, et al (2010). Notch promotes radioresistance of glioma stem cells. Stem Cells, 28, 17-28.
|
46 |
Wei P, Walls M, Qiu M, et al (2010). Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther, 9, 1618-28.
DOI
|
47 |
Wang M, Li JT, Zeng YX, Hou JH, Lin QQ. (2005). Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma. Ai Zheng, 24, 1230-4.
|
48 |
Wang Z, Li Y, Banerjee S, Sarkar FH (2008). Anticancer Res. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res, 28, 3621-30.
|
49 |
Wang Z, Li Y, Banerjee S, Sarkar FH (2009). Emerging role of Notch in stem cells and cancer. Cancer Lett, 279, 8-12.
DOI
|
50 |
Whitehead J, Thygesen H, Jaki T, et al (2012). A novel Phase I/ IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer. Stat Med, 31, 1931-43 .
DOI
|
51 |
Woodward WA, Chen MS, Behbod F, et al (2007). WNT/betacatenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A, 104, 618-23.
DOI
|
52 |
Wu Y, Cain-Hom C, Choy L, et al (2010). Therapeutic antibody targeting of individual Notch receptors. Nature, 464, 1052-7.
DOI
|
53 |
Xu X, Zhao Y, Xu M, et al (2011). Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. Med Oncol, 28, S483-9.
DOI
|
54 |
Yeung TM, Gandhi SC, Bodmer WF (2011). Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci U S A, 108, 4382-7.
DOI
|
55 |
Zhang AL, Russell PJ, Knittel T, Milross C (2007). Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Prostate, 67, 1630-40.
DOI
|
56 |
Yu J, Liu F, Sun M, Sun Z, Sun S (2011). Enhancement of radiosensitivity and the potential mechanism on human esophageal carcinoma cells by tetrandrine. Cancer Biother Radiopharm, 26, 437-42.
DOI
|
57 |
Yu S, Zhang R, Liu F, et al (2011). Down-regulation of Notch signaling by a gamma-secretase inhibitor enhances the radiosensitivity of nasopharyngeal carcinoma cells. Oncol Rep, 26, 1323-8.
|
58 |
Zaidi S, McLaughlin M, Bhide SA, et al (2012). The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage. PLoS One, 7, e35436.
DOI
|
59 |
Zhang X, Komaki R, Wang L, Fang B, Chang JY (2008). Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res, 14, 2813-23.
DOI
|
60 |
Zhang XP, Zheng G, Zou L, et al (2008). Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol. Cell. Biochem. 307, 101-8.
|
61 |
Zhang Y, Li B, Ji ZZ Zheng PS. (2010). Notch1 regulates the growth of human colon cancers. Cancer. 116, 5207-18.
DOI
|
62 |
Zhang Y, Peng J, Zhang H, et al. (2010). Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg, 39, 157-66.
|
63 |
Zhen Y, Zhao S, Li Q, Li Y, Kawamoto K (2010). Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett, 292, 64-72.
DOI
|
64 |
Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB (2008). Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest, 118, 3660-70.
DOI
|
65 |
Allen TD, Rodriguez EM, Jones KD, Bishop JM (2011). Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 71, 6010-8.
DOI
|
66 |
Artavanis-Tsakonas S, Rand MD, Lake RJ (1999). Notch signaling: cell fate control and signal integration in development. Science, 284, 770-6.
DOI
ScienceOn
|
67 |
Bao S, Wu Q, McLendon RE, et al (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60.
DOI
ScienceOn
|
68 |
Bischoff P, Altmeyer A, Dumont F (2009). Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers. Expert Opin Ther Pat, 19, 643-62.
DOI
|
69 |
Brou C, Logeat F, Gupta N, et al (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell, 5, 207-16.
DOI
|
70 |
Canman CE, Lim DS, Cimprich KA, et al (1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science, 281, 1677-9.
DOI
|
71 |
Chen YW, Chen KH, Huang PI, et al (2010). Cucurbitacin I suppressed stem-like property and enhanced radiationinduced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Mol Cancer Ther, 9, 2879-92.
DOI
|
72 |
Chen F, Pisklakova A, Li M, et al (2011). Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma. Cell Oncol (Dordr), 34, 545-51.
DOI
|
73 |
Chen SM, Liu JP, Zhou JX, et al (2011). Suppression of the notch signaling pathway by gamma-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation. Cancer Lett, 306, 76-84.
DOI
|
74 |
Chen Y, Li D, Liu H, et al (2011). Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells. Cancer Biol Ther, 11, 14-21.
DOI
|
75 |
Cohen-Jonathan E, Toulas C, Ader I, et al (1999). The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS. Radiat Res, 152, 404-11.
DOI
|
76 |
Cook N, Frese KK, Bapiro TE, et al (2012). Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. J Exp Med, 209, 437-44.
DOI
|
77 |
Cooper JS, Ang KK (2005). Concomitant chemotherapy and radiation therapy certainly improves local control. Int J Radiat Oncol Biol Phys, 61, 7-9.
DOI
|
78 |
Czito BG, Willett CG, Bendell JC, et al (2006). Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol, 24, 656-62.
DOI
|
79 |
Dai L, He J, Liu Y, et al (2011). Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with gamma-secretase inhibitor. Proteomics, 11, 4529-40.
DOI
|
80 |
Debeb BG, Cohen EN, Boley K, et al (2012). Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res Treat, 134, 495-510.
DOI
|
81 |
Deorukhkar A, Krishnan S (2010). Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol, 80, 1904-14.
DOI
ScienceOn
|
82 |
Dextraze ME, Cecchini S, Bergeron F, et al (2009). Reaching for the other side: generating sequence-dependent interstrand cross-links with 5-bromodeoxyuridine and gamma-rays. Biochemistry, 48, 2005-11.
DOI
|
83 |
Diehn M, Cho RW, Lobo NA, et al (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature, 458, 780-3.
DOI
ScienceOn
|
84 |
Dotto GP (2008). Notch tumor suppressor function. Oncogene, 27, 5115-23.
DOI
|
85 |
Dufraine J, Funahashi Y, Kitajewski J (2008). Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene, 27, 5132-37.
DOI
|
86 |
Efimova EV, Liang H, Pitroda SP, et al (2009). Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol, 85, 421-31.
DOI
|
87 |
Ellisen LW, Bird J, West DC, et al (1991). TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell, 66, 649-61.
DOI
|
88 |
Fan X, Khaki L, Zhu TS, et al (2010). NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 28, 5-16.
|
89 |
Garber K (2007). Notch emerges as new cancer drug target. J. Natl. Cancer Inst, 99, 1284-85.
DOI
|
90 |
Gil J, Stembalska A, Pesz KA, Sasiadek MM. (2008). Cancer stem cells: the theory and perspectives in cancer therapy. J Appl Genet, 49, 193-9.
DOI
|
91 |
Gogineni VR, Nalla AK, Gupta R, et al (2011). Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells. Cancer Lett, 313, 64-75.
DOI
ScienceOn
|
92 |
Guo S, Liu M, Gonzalez-Perez RR (2011). Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta, 1815, 197-213.
|
93 |
Hajdu M, Kopper L, Sebestyen A (2010). Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas. Scand J Immunol, 71, 29-37.
DOI
|
94 |
Harrison H, Farnie G, Howell SJ, et al (2010). Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res, 70, 709-18.
DOI
|
95 |
He Z, Subramaniam D, Ramalingam S, et al (2011). Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. Am J Physiol Gastrointest Liver Physiol, 301, G929-37.
DOI
|
96 |
Heidelberger C, Griesbach L, Cruz O, Schnitzer RJ, Grunberg E. (1958). Effects of 5-fluorouridine and 5-fluoro-2'-deoxyuridine on transplanted tumors. Proc Soc Exp Biol Med, 97, 470-5.
DOI
|
97 |
Hellstrom M, Phng LK, Hofmann JJ, et al (2007). Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature, 445, 776-80.
DOI
|
98 |
Hirose H, Ishii H, Mimori K, et al (2010). Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptornegative breast tumors. Oncol Rep, 23, 35-43.
|
99 |
Hovinga KE, Shimizu F, Wang R, et al (2010). Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells, 28, 1019-29.
DOI
|
100 |
Hosoki A, Yonekura S, Zhao QL, et al (2012). Mitochondriatargeted superoxide dismutase (SOD2) regulates radiation resistance and radiation stress response in HeLa cells. J Radiat Res, 53, 58-71.
DOI
|
101 |
Iliopoulos D, Hirsch HA, Wang G, Struhl K (2011). Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci U S A, 108, 1397-402.
DOI
|
102 |
Jehn BM, Bielke W, Pear WS, Osborne BA (1999). Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. J Immunol, 162, 635-8.
|
103 |
Jiang L, Wu J, Chen Q, et al (2011). Notch1 expression is upregulated in glioma and is associated with tumor progression. J Clin Neurosci, 18, 387-90.
DOI
|
104 |
Kato Y, Yashiro M, Fuyuhiro Y, et al (2011). Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells. Anticancer Res, 31, 3369-75.
|
105 |
Keysar SB, Jimeno A (2010). More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther, 9, 2450-57.
DOI
|
106 |
Kotowski U, Heiduschka G, Brunner M, et al (2011). Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane. Strahlenther Onkol, 187, 575-80.
DOI
|
107 |
Krop I, Demuth T, Guthrie T, et al (2012). Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors. J Clin Oncol, 30, 2307-13 .
DOI
|